Meati Foods confidently aims to achieve its $1bn sales target by 2025, despite the slowdown in demand for alternative-protein products in the US.
The Boulder, Colorado-based business, which recently secured additional funding for its Series C round, has expanded its distribution channels by introducing a direct-to-consumer service to complement its retail listings in Sprouts, Whole Foods Market, and Meijer.
In addition to retail, Meati Foods’ mycelium-based meat-free products, including chicken breast, breaded chicken cutlets, steak, and seasoned carne asada steak, are now available in thousands of foodservice locations. CEO Tyler Huggins emphasized the high demand and expressed confidence in reaching the $1bn target as previously announced by President Scott Tassani in the prior year.
Meati Foods is rapidly building its commercial platform and aggressively positioning itself for unprecedented growth. The company previously announced job cuts but did not provide further details.
Despite challenges, Meati Foods remains committed to its ambitious goals. Co-founder Tyler Huggins states that the company is currently making difficult decisions to establish a sustainable business model.
Meati Foods differentiates itself in taste, nutrition, and texture. With its mycelium-based products consisting of 95% to 97% mushroom root, the company believes it offers a great alternative for those seeking diversity in their diet.
Meati Foods aims to grow its presence in the US market and is expanding both its retail and foodservice partnerships. The company is actively using its recent funding to fuel further expansion.
Meati Foods focuses on providing nutrient-dense alternatives at a competitive price compared to conventional meat products. The company places a strong emphasis on its superior nutritional profile.
For now, Meati Foods remains dedicated to the US market, prioritizing delivering value to consumers.
The company’s recent achievements demonstrate its commitment to impact and growth. Meati Foods is poised for continued success.
